Front Page

Previous Story

Next Story

NIH Record vertical blue bar column separator
Gerberding To Speak on Today's Health Threats

Dr. Julie Gerberding, director of the Centers for Disease Control and Prevention, will deliver the 2003 Kinyoun Lecture on Friday, Oct. 24. Her lecture, titled "21st-Century Health Threats: The New Normal," will begin at 3 p.m. in Masur Auditorium, Bldg. 10. The Kinyoun Lecture is sponsored by NIAID.

As leader of CDC, Gerberding guides the national response to bioterrorism threats and emerging diseases such as SARS and West Nile virus. During the anthrax attacks of 2001, while she was acting deputy director of CDC's National Center for Infectious Diseases, she demonstrated her effectiveness in responding to the simultaneous needs of the news media, senior government officials and the public.

Dr. Julie Gerberding, director of the Centers for Disease Control and Prevention

On July 3, 2002, Health and Human Services Secretary Tommy Thompson appointed her director of CDC, an agency that promotes health and quality of life by preventing and controlling disease, injury and disability.

Gerberding first joined CDC as director of the Division of Health Care Quality Promotion (formerly the Hospital Infections Program) in 1998. Previously, she was director of the infection prevention center at the University of California, San Francisco, and had held various teaching and professional appointments at UCSF since 1984. She continues to hold an associate professorship at the University of California and is also an associate clinical professor of medicine at Emory University.

Both a teacher and physician, Gerberding has worked on public health issues, primarily HIV and AIDS, for more than 20 years. Her consulting work for national and international public health agencies shaped guidelines for preventing the occupational spread of HIV in hospitals and other health care settings. She has written or co-written more than 120 peer-reviewed publications and textbook chapters.

National and international public health agencies, including NIH, CDC and the World Health Organization have frequently sought her advice on HIV and AIDS. At UCSF in the early 1980s, Gerberding treated patients with a mysterious illness now known to be AIDS. She served on the San Francisco mayor's AIDS task force from 1985 to 1987. Between 1985 and 1989, she also advised the American Medical Association on HIV risk among health care providers, CDC on HIV/AIDS infection control guidelines and NIH on ethical responsibilities of AIDS caregivers.

Reared in Brookings, S. Dak., Gerberding earned her B.A. degree magna cum laude in chemistry/biology and her M.D. degree from Case Western Reserve University. After her internship and residency at UCSF, she became chief medical resident. She completed a fellowship in clinical pharmacology and infectious diseases there in 1988. She earned a master's degree in public health from the University of California, Berkeley, in 1990.

Gerberding has received several honors and awards. She is a member of Phi Beta Kappa honor society and Alpha Omega Alpha medical honor society. In 2001, she received the HHS Distinguished Service Award, and in 1997, she was named a fellow of the Infectious Diseases Society of America.

The Kinyoun Lecture is dedicated to the memory of Dr. Joseph J. Kinyoun who founded the Laboratory of Hygiene in 1887. The present-day NIH evolved from Kinyoun's original one-room laboratory on Staten Island.


Up to Top